Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases-Reference-Cited by-同舟云学术

Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases

Published:2023-03 Issue:2 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Hümmert Martin W.¹,Bütow Franziska¹,Tkachenko Daria¹,Ayzenberg Ilya¹,Pakeerathan Thivya¹,Hellwig Kerstin¹,Klotz Luisa¹,Häußler Vivien¹,Stellmann Jan-Patrick¹,Warnke Clemens¹,Goereci Yasemin¹,Etgen Thorleif¹,Luessi Felix¹,Bronzlik Paul¹,Gingele Stefan¹,Lauenstein Ann-Sophie¹,Kleiter Ingo¹,Rommer Paulus S.¹,Paul Friedemann¹,Bellmann-Strobl Judith¹,Duchow Ankelien¹,Then Bergh Florian¹,Pul Refik¹,Walter Annette¹,Pellkofer Hannah¹,Kümpfel Tania¹,Pompsch Mosche¹,Kraemer Markus¹,Albrecht Philipp¹,Aktas Orhan¹,Ringelstein Marius¹,Senel Makbule¹,Giglhuber Katrin¹,Berthele Achim¹,Jarius Sven¹,Wildemann Brigitte¹,Trebst Corinna¹

Affiliation:

1. From the Department of Neurology (M.W.H., F.B., D.T., S.G., C.T.), Hannover Medical School, Germany; Department of Neurology (I.A., T.P., K.H., I.K.), St. Josef Hospital, Ruhr University Bochum, Germany; Department of Neurology (L.K.), University of Münster, Germany; Department of Neurology and Institute of Neuroimmunology and MS (INIMS) (V.H., J.-P.S.), University Medical Center Hamburg-Eppendorf, Germany; Aix-Marseille Univ (J.-P.S.), CNRS, CRMBM, UMR 7339, Marseille Cedex, France; APHM (J.-P.S.),...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200082

Reference48 articles.

1. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

2. Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis

3. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

4. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

5. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD;Immunity, Inflammation and Disease;2024-01

2. The impact of COVID-19 on a Southern Chinese cohort with neuromyelitis optica spectrum disorders;Multiple Sclerosis and Related Disorders;2024-01

3. Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview;Clinical and Experimental Neuroimmunology;2023-12-19

4. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management;Journal of Neurology;2023-09-07

5. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management;J NEUROL;2023